InSitu Biologics Shares Latest Investigational Work at ASRA Meeting

OAKDALE, Minn.--(BUSINESS WIRE)--InSitu Biologics, Inc. will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th, 2022. The presentation entitled “Tunable Pharmacokinetics Of A Local Anesthetic Using A Multi-Phase Drug Delivery Matrix” was authored by InSitu Biologics team members: Bill Taylor, Chief Science Officer; Dr. Kelsey Pflepsen, Formulation Scienti